2014
DOI: 10.1177/1078155214556522
|View full text |Cite
|
Sign up to set email alerts
|

Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology

Abstract: This international snapshot provides important data about the level of implementation of system-based safeguards in oncology practice, key improvement opportunities, and represents a baseline for future improvement efforts. A collaborative approach to identifying vulnerabilities and developing solutions for safe medication use in oncology will enhance the care of patients with cancer internationally.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 8 publications
0
15
0
Order By: Relevance
“…These guidelines intended to involve all the stakeholders, to be comprehensive and applicable to individuals and institutions. In a recent multinational study by the International Medication safety Practice (ISMP) and International Medication safety Practice Canada (ISMPC) addressing system based safeguards in Oncology practice identified OAAs as a key areas that needs improvement (Greenall et al, 2015). How to implement and adapt these guidelines and monitor their applications remains a major challenge.…”
Section: Discussionmentioning
confidence: 99%
“…These guidelines intended to involve all the stakeholders, to be comprehensive and applicable to individuals and institutions. In a recent multinational study by the International Medication safety Practice (ISMP) and International Medication safety Practice Canada (ISMPC) addressing system based safeguards in Oncology practice identified OAAs as a key areas that needs improvement (Greenall et al, 2015). How to implement and adapt these guidelines and monitor their applications remains a major challenge.…”
Section: Discussionmentioning
confidence: 99%
“…The Brazilian health legislation mandates that top-level professionals in health 12 should perform the preparation of antineoplastic therapy. Handling by poorly trained professionals may favor occupational exposure, process failures, and patient risks 13 . As pointed out, the pharmacist tried to explain this practice precisely on grounds of patient safety, in addition to mentioning the limited number of pharmacists (two) working in oncology inside the facility.…”
Section: Organizational Structurementioning
confidence: 99%
“…Those suggestions based on General Administration of Pharmaceutical strategic goals and Saudi Central Board of Accreditation for Health Care Institutions (CBAHI) standards in Saudi Arabia. [1][2][3][4][5][6][7][8][9][10][11][12][13] The ten domains divided into for several parts for analysis, discussion, and solution. Part one: patient information, part two: drug information, part three: medication preparation and dispensing (communication of drug orders and other drug information, drug Labeling and Packaging and Nomenclature).…”
Section: Methodsmentioning
confidence: 99%
“…[10,11] Another study in 2012 investigated a bout self-assessment of oncology medication. [12] The authors are not familiar with any study published about ISMP self-assessment finding in Saudi Arabia, Gulf countries or Middle East countries and thus it is the first study done in our area. Also, the advantage of this study, it did during the mass gathering Hajj period and may be the first survey of this property in the world.…”
Section: Introductionmentioning
confidence: 99%